MENU A Haemostasis partner to trust MediRox is one of the market leaders in Scandinavia among the producers of haemostasis diagnostic reagents and controls. See all products R & D A true innovation centre Production High coordination for the highest quality Latest News Ahead Global Investment Ltd:s budpliktserbjudande till aktieägarna i MediRox AB 26 October 2016 I enlighet med reglerna om budplikt i Kollegiets för svensk bolagsstyrning regler rörande offentliga uppköpserbjudanden avseende aktier i svenska aktiebolag vilkas aktier handlas på vissa handelsplattformar. Pressrelease Budpliktsbud 19 October 2016 Ahead Global Investment Ltd offentliggör ett kontant budpliktsbud till MediRox aktieägare. MediRox holds a scientific conference in Vilnius, Lithuania 17 October 2016 MediRox together with the local distributors in Lithuania held a scientific conference which was dedicated to the World's Thrombosis Day, MediRox holds an internal conference on communication 06 October 2016 On October 3-5th MediRox had an internal conference for the employees with focus on efficient communications. Pressrelease Ersättningsinvestering 25 September 2016 MediRox AB gör ersättningsinvestering i produktionsutrustning värd ca 4,5 miljoner kronor. Previous Next Coagulation reagents MRX APTT A screening test for hemostatic defects in the intrinsic and common pathway of the coagulation cascade. MRX Fib Clauss For quantitative determination of fibrinogen in plasma, according to the Clauss method. MRX D-Dimer Intended for quantification of D-dimer concentration in plasma. MRX AT For determination of the antithrombin (AT) activity in plasma for diagnosis of AT deficiency. MRX Owren's PT Owren’s Prothrombin Time (PT) can be used to monitor oral anticoagulant therapy and be used as a screening test for defects in the extrinsic pathway. MRX PT Quick Can be used as a screening test of deficiency in coagulation factors in the extrinsic pathway and for determination of prothrombin time (PT) in patients administered on vitamin K-antagonists. MRX TT Intended for determination of the thrombin time (TT) in plasma for detection of fibrinogen pathologies. MediRox is a Swedish producer of high quality control plasmas and diagnostic reagents for routine coagulation assays. Sales Årstaängsvägen 21C SE-117 43 Stockholm see map E-mail: sales@medirox.se Phone: +46 (0) 155 45 44 10 R & D Linköping University Hospital SE-581 85 Linköping see map E-mail: research@medirox.se Phone: +46 (0) 155 45 Order Studsvik SE-611 82 Nyköping see map E-mail: order@medirox.se Phone: +46 (0) 155 45 44 10 @2016 Medirox AB Linked in Twitter Facebook Home About Research & Development Order & Production Sales & Marketing Haemostasis History Products Coagulation Reagents MRX APTT MRX Fib Clauss MRX D-Dimer MRX AT MRX Owren's PT MRX PT Quick MRX TT Coagulation Controls Eximius Controls Scandinavian Controls PT Control INR 5 Downloads Investors Investor news Investor background Reports News Contact MRX A 14.30 sek1.78 % MRX B12.90 sek 0.00 % 28 Oct 2016, 13.24